We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 10,000 results
  1. A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles

    Vaccines against infectious diseases should elicit potent and long-lasting immunity, ideally even in those with age-related decline in immune...

    Ryoma Nakao, Hirotaka Kobayashi, ... Makoto Ohnishi in npj Vaccines
    Article Open access 26 November 2022
  2. Antigenic and immunogenic properties of recombinant proteins consisting of two immunodominant African swine fever virus proteins fused with bacterial lipoprotein OprI

    Background

    African swine fever (ASF) is a highly fatal swine disease, which threatens the global pig industry. There is no commercially available...

    Guanglei Zhang, Wei Liu, ... Huiyun Chang in Virology Journal
    Article Open access 21 January 2022
  3. The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory

    Background

    Cancer recurrence is a serious problem in breast cancer (BC) patients, and immunogenic cell death (ICD) has been proposed as a strategy to...

    Alejandra Reyes-Ruiz, Kenny Misael Calvillo-Rodriguez, ... Cristina Rodríguez-Padilla in British Journal of Cancer
    Article Open access 03 February 2021
  4. The potential utility of hybrid photo-crosslinked hydrogels with non-immunogenic component for cartilage repair

    Finding a suitable biomaterial for scaffolding in cartilage tissue engineering has proved to be far from trivial. Nonetheless, it is clear that...

    Yili Wang, Levinus Hendrik Koole, ... Huaqiong Li in npj Regenerative Medicine
    Article Open access 10 September 2021
  5. Identification of a Cyclospora cayetanensis Oocyst Antigens and Their Validity in the Detection of Immunogenic Patterns of Cyclosporiasis Patients

    Introduction

    The diagnosis of cyclosporiasis is currently based on the microscopic detection of oocysts, which may provide invalid results. The...

    Eman M. Hussein, Eman K. El-Gayar, ... Maha M. Al-Abbassy in Acta Parasitologica
    Article 10 October 2020
  6. IL-33 and IL-33-derived DC-based tumor immunotherapy

    Interleukin-33 (IL-33), a member of the IL-1 family, is a cytokine released in response to tissue damage and is recognized as an alarmin. The...

    Myeong-Ho Kang, Yong-Soo Bae in Experimental & Molecular Medicine
    Article Open access 03 June 2024
  7. The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex

    Neoantigens are ideal targets for cancer immunotherapy because they are expressed de novo in tumor tissue but not in healthy tissue and are therefore...

    Sang Hoon Kim, Bo Ryeong Lee, ... Woong-Yang Park in Experimental & Molecular Medicine
    Article Open access 12 June 2024
  8. Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets

    Influenza viruses cause annual seasonal epidemics and sporadic pandemics; vaccination is the most effective countermeasure. Intranasal live...

    Jasmina M. Luczo, Tatiana Bousse, ... Stephen M. Tompkins in npj Vaccines
    Article Open access 21 April 2021
  9. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy

    Current cancer immunotherapy has limited response rates in a large variety of solid tumors partly due to the low immunogenicity of the tumor cells...

    **g Gao, Wei-qi Wang, ... Hai-jun Yu in Acta Pharmacologica Sinica
    Article Open access 21 April 2020
  10. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy

    Background

    Hepatocellular carcinoma (HCC) is one of the most common and devastating malignancies. Oxaliplatin, a platinum-based chemotherapeutic...

    Hanzhang Zhu, Yuqiang Shan, ... Changku Jia in Cellular Oncology
    Article 14 August 2020
  11. Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression

    Background

    Mitoxantrone (MTX) is a synthetic compound used as a second line chemotherapeutic drug for prostate cancer. It has been reported to trigger...

    Changlin Li, Hui Sun, ... Benyi Li in Cellular Oncology
    Article 24 July 2020
  12. Actin-depolymerizing factor from Eimeria tenella promotes immunogenic function of chicken dendritic cells

    Dendritic cells play a crucial role in inducing antigen-specific immunity to pathogens. During host-parasite interaction, host immune response to the...

    Shakeel Ahmed Lakho, Muhammad Haseeb, ... **angRui Li in Parasitology Research
    Article 13 January 2021
  13. ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

    Background

    Immunotherapy with checkpoint inhibitors (CI) represents an important novel development in cancer treatment. Metastatic triple-negative...

    J. A. Kyte, A. Røssevold, ... B. Naume in Journal of Translational Medicine
    Article Open access 23 June 2020
  14. Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design

    Background

    Cancer immunotherapies such as bispecific T-cell engagers have seen limited adoption in prostate cancer (PC), possibly due to differing...

    Eske N. Glud, Martin Rasmussen, ... Kenneth A. Howard in British Journal of Cancer
    Article Open access 15 October 2022
  15. Methods to Detect Immunogenic Cell Death In Vivo

    In response to selected stressors, cancer cells can undergo a form of regulated cell death that—in immunocompetent syngeneic hosts—is capable of...
    Takahiro Yamazaki, Aitziber Buqué, ... Lorenzo Galluzzi in Biomarkers for Immunotherapy of Cancer
    Protocol 2020
  16. Production of immunogenic recombinant L1 protein of bovine papillomavirus type 9 causing teat papillomatosis

    Bovine papillomavirus type 9 (BPV9) is a causative agent of severe teat papillomatosis. Considering the lack of efficient BPV culture methods,...

    Satoko Watanabe, Tomoyuki Shibahara, ... Masaji Mase in Archives of Virology
    Article 01 April 2020
  17. Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics

    The identification and removal of host cell proteins (HCPs) from biologic products is a critical step in drug development. Despite recent...

    Kirk Haltaufderhyde, Brian J. Roberts, ... Anne S. De Groot in The AAPS Journal
    Article Open access 11 September 2023
  18. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells

    Background

    Chemotherapeutics can stimulate immune antitumor response by inducing immunogenic cell death (ICD), which is activated by Damage-Associated...

    José Ignácio Gonzalez Solari, Eduardo Filippi-Chiela, ... Fábio Klamt in BMC Cancer
    Article Open access 26 May 2020
Did you find what you were looking for? Share feedback.